MD Anderson and Nexo Ink discovery deal for undruggable targets
“The University of Texas MD Anderson Cancer Center and start up [MORE]
RNA therapeutics
“RNA Therapeutics is a rapidly emerging field of biotherapeutics. These therapies are based upon powerful and versatile platform which [MORE]